2 The findings from the OASIS 4 trial, published in the New England Journal of Medicine in September 2025, led the FDA to approve the Wegovy pill in December 2025, making it the first oral GLP-1 medication approved specifically for weight loss
Improved Sleep Quality Growth hormone is naturally released in deep sleepespecially during slow-wave cycles
In relation to combination therapy, amylin receptor agonism has raised significant interest as a possible candidate, since it has the potential for significant weight reduction and improved glucose control in both preclinical and clinical studies [2, 30, 38]
If alterations in AT cause the lower IR in PWS, it is not surprising that these studies failed to find lower IR in PWS
I used to take MaxGXL, and this is the same product but less expensive